Literature DB >> 18507673

Metabolic syndrome and three of its components as risk factors for recurrent ischaemic stroke presenting as large-vessel infarction.

C-W Liou1, T-Y Tan, T-K Lin, P-W Wang, H-K Yip.   

Abstract

BACKGROUND AND
PURPOSE: Although a clear protocol for reduction of recurrent ischaemic stroke (RIS) has been established, few studies have compared the stroke subtype distribution and risk factors between RIS and first-ever stroke (FES).
METHODS: This one-year hospital-based study enrolled 587 FES and 475 RIS patients. Patients were categorized into four stroke subtypes according to a modified TOAST stroke subtype classification system. Risk factor profiles were compared between the two major stroke groups and between the corresponding four subtypes to discriminate the significant risk factors for RIS.
RESULTS: A multivariate regression analysis identified hypertension (OR, 1.87; 95% CI, 1.34-2.62), diabetes mellitus (DM) (OR, 1.57; 95% CI, 1.22-2.02), low high-density lipoprotein (LHDL) (OR, 1.43; 95% CI, 1.08-1.88) and older age as significant RIS risk factors. The significance of the former three RIS factors was further recognized in its large-vessel subtype. Moreover, metabolic syndrome was significantly more common in the recurrent stroke group (P = 0.01), including its large-vessel subtype (P = 0.04). Progressively increasing odds ratios from 1.49 to 2.02, in accordance with increased number of diagnostic components of metabolic syndrome for recurrent large-vessel ischaemic stroke, were noted.
CONCLUSIONS: Metabolic syndrome likely plays a crucial role in the development of RIS, including large-vessel infarction in modern-day Taiwan.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18507673     DOI: 10.1111/j.1468-1331.2008.02181.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  12 in total

1.  Cardiovascular fitness training for a patient in the early stages of recovery post stroke.

Authors:  Marilyn Mackay-Lyons; Marianne Thornton; Alison Macdonald
Journal:  Physiother Can       Date:  2011-08-10       Impact factor: 1.037

2.  Evaluation of metabolic syndrome in patients with chronic low back pain.

Authors:  Mehmet Tuncay Duruöz; Yasemin Turan; Alev Gürgan; Hülya Deveci
Journal:  Rheumatol Int       Date:  2010-12-05       Impact factor: 2.631

3.  Program of rehabilitative exercise and education to avert vascular events after non-disabling stroke or transient ischemic attack (PREVENT Trial): a multi-centred, randomised controlled trial.

Authors:  Marilyn MacKay-Lyons; Gordon Gubitz; Nicholas Giacomantonio; Howard Wightman; David Marsters; Kara Thompson; Chris Blanchard; Gail Eskes; Marianne Thornton
Journal:  BMC Neurol       Date:  2010-12-08       Impact factor: 2.474

4.  Metabolic syndrome and the short-term prognosis of acute ischemic stroke: a hospital-based retrospective study.

Authors:  Liu Liu; Lixuan Zhan; Yisheng Wang; Chengping Bai; Jianjun Guo; Qingyuan Lin; Donghai Liang; En Xu
Journal:  Lipids Health Dis       Date:  2015-07-22       Impact factor: 3.876

5.  Recurrent Stroke in Minor Ischemic Stroke or Transient Ischemic Attack With Metabolic Syndrome and/or Diabetes Mellitus.

Authors:  Weiqi Chen; Yuesong Pan; Jing Jing; Xingquan Zhao; Liping Liu; Xia Meng; Yilong Wang; Yongjun Wang
Journal:  J Am Heart Assoc       Date:  2017-06-01       Impact factor: 5.501

6.  In-hospital medical complications associated with stroke recurrence after initial ischemic stroke: A prospective cohort study from the China National Stroke Registry.

Authors:  Penglian Wang; Yilong Wang; Xingquan Zhao; Wanliang Du; Anxin Wang; Gaifen Liu; Liping Liu; Ruijun Ji; Chunxue Wang; Kehui Dong; Yongjun Wang
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

7.  Increased mean carotid intima media thickness in type 2 diabetes mellitus patients with non-blood pressure component metabolic syndrome: A preliminary report.

Authors:  Marwan S M Al-Nimer; Ismail I Hussein
Journal:  Int J Diabetes Dev Ctries       Date:  2009-01

8.  Metabolic syndrome and stroke recurrence in Chinese ischemic stroke patients--the ACROSS-China study.

Authors:  Donghua Mi; Qian Jia; Huaguang Zheng; Kolin Hoff; Xingquan Zhao; Chunxue Wang; Gaifen Liu; Yilong Wang; Liping Liu; Xianwei Wang; Yongjun Wang
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240

9.  Impact of metabolic syndrome on the prognosis of ischemic stroke secondary to symptomatic intracranial atherosclerosis in Chinese patients.

Authors:  Donghua Mi; Liqun Zhang; Chunxue Wang; Liping Liu; Yuehua Pu; Xingquan Zhao; Yilong Wang; Yongjun Wang
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

10.  Association of Diabetes and Prognosis of Minor Stroke and Its Subtypes: A Prospective Observational Study.

Authors:  Yuesong Pan; Yongjun Wang; Hao Li; Herbert Y Gaisano; Yilong Wang; Yan He
Journal:  PLoS One       Date:  2016-04-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.